Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-lowering interventions in managed care settings.

J Fox1, K Jones

  • 1M-Plan, Indianapolis, Indiana, USA.

The American Journal of Medicine
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic performance of phase-contrast computed tomography versus digital mammography: A pilot study.

Radiography (London, England : 1995)·2026
Same author

The Experiences of Native Irish speaking Older Adults Navigating Healthcare Services.

Irish medical journal·2024
Same author

Memory support training and lifestyle modifications to promote healthy aging in persons at risk for Alzheimer's disease: a digital application supported intervention (Brain Boosters).

BMC geriatrics·2023
Same author

Data registration for multi-method qualification of additive manufactured components.

Additive manufacturing·2023
Same author

The influence of frailty on outcomes for older adults admitted to hospital with benign biliary disease: a single-centre, observational cohort study.

Annals of the Royal College of Surgeons of England·2022
Same author

Measuring High-Order Phonon Correlations in an Optomechanical Resonator.

Physical review letters·2022
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Improving lipid management is crucial for preventing coronary heart disease (CHD). Quality improvement programs and physician education can enhance lipid-lowering therapy effectiveness and reduce healthcare costs.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Elevated serum lipid levels strongly correlate with coronary heart disease (CHD).
  • Current screening, treatment, and follow-up for hyperlipidemia are often inadequate in managed care settings.
  • Suboptimal utilization of lipid-lowering therapy limits primary and secondary prevention of CHD.

Purpose of the Study:

  • To evaluate the effectiveness of a quality improvement program for hyperlipidemia management.
  • To identify strategies for enhancing the efficacy and cost-effectiveness of lipid-lowering therapies.
  • To reduce CHD-related morbidity, mortality, and economic burden.

Main Methods:

  • A three-phase hyperlipidemia outcomes management program conducted at 27 US managed care organizations (MCOs).

Related Experiment Videos

  • Implementation of physician education and integrated quality improvement initiatives.
  • Individualized drug selection and dosage adjustments to meet National Cholesterol Education Program goals.

    • Main Results:

    • Findings from the initial phase confirmed suboptimal hyperlipidemia management practices.
    • Physician education and quality improvement programs demonstrated potential to enhance lipid-lowering therapy efficacy.
    • Individualized treatment strategies can improve cost-effectiveness by optimizing drug acquisition costs.

    Conclusions:

    • Comprehensive quality improvement programs can significantly improve hyperlipidemia management.
    • Enhanced physician education and tailored therapeutic approaches are key to optimizing lipid-lowering therapy.
    • These interventions hold the potential to decrease CHD-related health issues and associated economic costs.